Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool

• Main Authors: Patricia Marañón (Author), Carlos Ernesto Fernández-García (Author), Stephania C. Isaza (Author), Esther Rey (Author), Rocío Gallego-Durán (Author), Rocío Montero-Vallejo (Author), Javier Rodríguez de Cía (Author), Javier Ampuero (Author), Manuel Romero-Gómez (Author), Carmelo García-Monzón (Author), Águeda González-Rodríguez (Author)
• Format: Book
• Published: BMC, 2022-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Non-alcoholic fatty liver disease (NAFLD) is the commonest cause of chronic liver disease worldwide, being non-alcoholic steatohepatitis (NASH) its most clinically relevant form. Given the risks associated with taking a liver biopsy, the design of accurate non-invasive methods to...